| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-069833 |
| cik | 1841387 |
| name | CANDEL THERAPEUTICS, INC. |
| sic | 2836 |
| countryba | US |
| stprba | MA |
| cityba | NEEDHAM |
| zipba | 02494 |
| bas1 | 117 KENDRICK STREET |
| bas2 | SUITE 450 |
| baph | 617-916-5445 |
| countryma | US |
| stprma | MA |
| cityma | NEEDHAM |
| zipma | 02494 |
| mas1 | 117 KENDRICK STREET |
| mas2 | SUITE 450 |
| countryinc | US |
| stprinc | DE |
| ein | 522214851 |
| former | CANDEL THERAPEUTICS, INIC. |
| changed | 20210120 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-13 08:31:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | cadl-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-069833 | 20240331 | Net Income Loss | -8221000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Accretion Of Debt Discount | 83000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20240331 | Common Stock Shares Outstanding | 29470076.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20240331 | Fair Value Adjustment Of Warrants | -7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Increase Decrease In Other Operating Assets | -14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Interest Expense Nonoperating | 306000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Interest Paid Net | 549000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Interest Paid Net | 252000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Liabilities | 21230000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Net Cash Provided By Used In Financing Activities | -1870000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Accretion Of Debt Discount | 44000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20240331 | Adjustments To Additional Paid In Capital Mark To Market | 13000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Adjustments To Additional Paid In Capital Mark To Market | 13000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 798000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20240331 | Net Income Loss | -8221000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069833 | 20240331 | Non Cash Interest Expense | 30000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20241231 | Other Assets | 63000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Proceeds From Principal Payments On Term Loan | -1667000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20250331 | Proceeds From Stock Options Exercised | 246000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Stockholders Equity | 493000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Stockholders Equity | -184826000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Shares Restricted Stock Unit Vesting | 330779.0000 | shares | 1 | 0000950170-25-069833 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value Exercise Of Pre Funded Warrants | 19000.0000 | USD | 1 | 0000950170-25-069833 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20220731 | Stock Issued During Period Value New Issues | 200000000.0000 | USD | 0 | us-gaap/2024 | Range= Maximum; Subsidiary Sale Of Stock= Combination Of Common Stock Preferred Stock Debt Securities Warrants And Units; | ||
| 0000950170-25-069833 | 20240331 | Stock Issued During Period Value New Issues | 186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 225000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20231231 | Treasury Stock Common Shares | -122608.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-069833 | 20240331 | Treasury Stock Common Shares | -122608.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-069833 | 20250331 | Treasury Stock Common Shares | -122608.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-069833 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 54765842.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 102920000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Common Stock Shares Outstanding | 46933088.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20240331 | Interest And Other Income | 320000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Non Cash Interest Expense | 34000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20240331 | Payments To Acquire Property Plant And Equipment | 7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-069833 | 20240331 | Profit Loss | -8221000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20231231 | Stockholders Equity | -137028000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069833 | 20241231 | Stockholders Equity | 258511000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20250430 | Stock Issued During Period Shares New Issues | 833011.0000 | shares | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= At The Market Offering; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 306518.0000 | shares | 1 | us-gaap/2024 | Plan Name= Two Thousand Fifteen Stock Plan; | ||
| 0000950170-25-069833 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 245000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 16000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Accounts Payable Current | 237000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Assets | 95905000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Cash And Cash Equivalents At Carrying Value | 102654000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 92431000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-069833 | 20250331 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Common Stock Shares Outstanding | 46810480.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Common Stock Value | 469000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Common Stock Value | 493000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Depreciation | 251000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Depreciation | 245000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Earnings Per Share Basic | 0.1500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Issuance Costs In Accounts Payable And Accrued Expenses | -25000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20241231 | Liabilities Current | 37529000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Long Term Loans From Bank | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Net Cash Provided By Used In Financing Activities | -1255000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Nonoperating Income Expense | 15509000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Operating Lease Liability Noncurrent | 407000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Operating Lease Liability Noncurrent | 257000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250430 | Proceeds From Issuance Of Common Stock | 4000000.0000 | USD | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= At The Market Offering; | ||
| 0000950170-25-069833 | 20250331 | Profit Loss | 7379000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Retained Earnings Accumulated Deficit | -184826000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Stockholders Equity | 66327000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Stockholders Equity | -448000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 1947192.0000 | shares | 1 | 0000950170-25-069833 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Shares New Issues | 2976391.0000 | shares | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Offering; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 118356.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20240331 | Stock Issued During Period Value New Issues | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value New Issues | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Treasury Stock Value | 448000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 29197537.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Assets Current | 93148000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Additional Paid In Capital Common Stock | 258511000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Cash And Cash Equivalents At Carrying Value | 92165000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 35679000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Common Stock Shares Issued | 46933088.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Earnings Per Share Diluted | 0.1300 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | General And Administrative Expense | 4114000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Increase Decrease In Accrued Liabilities | -1584000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Increase Decrease In Operating Lease Liability | -123000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Interest And Other Income | 934000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Net Cash Provided By Used In Investing Activities | -7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Net Income Loss | 7379000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069833 | 20240331 | Operating Expenses | 7902000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Operating Income Loss | -7902000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Operating Lease Liability Current | 566000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Proceeds From Stock Options Exercised | 226000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20231231 | Stockholders Equity | 12745000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20231231 | Stockholders Equity | 149931000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20231231 | Stockholders Equity | 290000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20231231 | Stockholders Equity | -448000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-069833 | 20240331 | Stockholders Equity | 151384000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20241231 | Stockholders Equity | -192205000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069833 | 20250331 | Stockholders Equity | -448000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-069833 | 20241231 | Stock Issued During Period Shares New Issues | 12000001.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Public Offering; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value Restricted Stock Unit Vesting | -3000.0000 | USD | 1 | 0000950170-25-069833 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20241231 | Treasury Stock Common Shares | -122608.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-069833 | 20240331 | Stock Issued During Period Shares New Issues | 109485.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Accounts Payable Current | 760000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Accrued Liabilities Current | 5113000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1030000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1030000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -10489000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-069833 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Common Stock Shares Issued | 49369749.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Increase Decrease In Accounts Payable | 507000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Liabilities | 40539000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Long Term Debt Current | 9895000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Long Term Debt Current | 9172000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Net Income Loss | 7379000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Non Cash Lease Expense | 74000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20240331 | Nonoperating Income Expense | -319000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Operating Lease Right Of Use Asset | 468000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Proceeds From Issuance Of Common Stock | 16200000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Offering; | ||
| 0000950170-25-069833 | 20250331 | Proceeds From Principal Payments On Term Loan | -2500000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20240331 | Research And Development Expense | 4102000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Share Based Compensation | 1043000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Share Based Compensation | 314000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Stockholders Equity | 74675000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value New Issues | 383000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 226000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Additional Paid In Capital Common Stock | 259456000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20231231 | Common Stock Shares Outstanding | 29213627.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20240331 | Earnings Per Share Diluted | -0.2800 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Issuance Costs Related To Common Stock And Accompanying Pre- Funded Warrants In Public Offering | 25000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20240331 | Non Cash Lease Expense | 65000.0000 | USD | 1 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Prepaid Expense And Other Assets Current | 1150000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Property Plant And Equipment Net | 1965000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Retained Earnings Accumulated Deficit | -192205000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Stockholders Equity | 292000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20240331 | Stockholders Equity | -448000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Shares New Issues | 40334.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 146964.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 118356.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value Exercise Of Pre Funded Warrants | -19000.0000 | USD | 1 | 0000950170-25-069833 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20220731 | Stock Issued During Period Value New Issues | 75000000.0000 | USD | 0 | us-gaap/2024 | Range= Maximum; Subsidiary Sale Of Stock= At The Market Offering; | ||
| 0000950170-25-069833 | 20240331 | Stock Issued During Period Value New Issues | 185000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20250331 | Adjustments To Additional Paid In Capital Mark To Market | -484000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Adjustments To Additional Paid In Capital Mark To Market | -484000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20241231 | Assets | 106866000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20190331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | Class Of Warrant Or Right= N C Ohio Trust Warrants; | ||
| 0000950170-25-069833 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Common Stock Shares Outstanding | 49247141.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Common Stock Shares Outstanding | 49369749.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Fair Value Adjustment Of Warrants | -14881000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Increase Decrease In Accounts Payable | 50000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Increase Decrease In Accrued Liabilities | -2368000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Increase Decrease In Other Operating Assets | -5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -167000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Liabilities Current | 20069000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Long Term Loans From Bank | 1733000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Other Long Term Debt Noncurrent | 870000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Other Long Term Debt Noncurrent | 904000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Prepaid Expense And Other Assets Current | 983000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Proceeds From Issuance Of Common Stock | 186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Proceeds From Issuance Of Common Stock | 384000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Restricted Cash Noncurrent | 266000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Stockholders Equity | 259456000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value Restricted Stock Unit Vesting | 3000.0000 | USD | 1 | 0000950170-25-069833 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 246000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Treasury Stock Value | 448000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Warrant Liability Current | 21718000.0000 | USD | 0 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20250331 | Warrant Liability Current | 6837000.0000 | USD | 0 | 0000950170-25-069833 | |||
| 0000950170-25-069833 | 20250331 | Accrued Liabilities Current | 2720000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 798000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Assets Current | 103804000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 25979000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -9700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Earnings Per Share Basic | -0.2800 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | General And Administrative Expense | 3800000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Increase Decrease In Operating Lease Liability | -136000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 39000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Interest Expense Nonoperating | 646000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Issuance Costs Related To Common Stock And Accompanying Pre- Funded Warrants In Public Offering | 25000.0000 | USD | 1 | 0000950170-25-069833 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069833 | 20241231 | Liabilities And Stockholders Equity | 106866000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Liabilities And Stockholders Equity | 95905000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Net Cash Provided By Used In Investing Activities | -3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Net Cash Provided By Used In Operating Activities | -8438000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Net Cash Provided By Used In Operating Activities | -8616000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Operating Expenses | 8130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Operating Income Loss | -8130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Operating Lease Liability Current | 580000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Operating Lease Right Of Use Asset | 542000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Other Assets | 58000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Payments To Acquire Property Plant And Equipment | 3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-069833 | 20241231 | Property Plant And Equipment Net | 2191000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Research And Development Expense | 4016000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Restricted Cash Noncurrent | 266000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Stockholders Equity | 5979000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20240331 | Stockholders Equity | -145249000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069833 | 20241231 | Stockholders Equity | 469000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20241231 | Stock Issued During Period Shares New Issues | 2000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value New Issues | 384000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069833 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 29197537.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069833 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 50482278.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Non Cash Lease Expense | 0000950170-25-069833 | 1 | 0 | monetary | D | D | Non-cash lease expense | Non-cash lease expense. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Treasury Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Long Term Loans From Bank | us-gaap/2024 | 0 | 0 | monetary | I | C | Loans Payable to Bank, Noncurrent | Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Issuance Costs Related To Common Stock And Accompanying Pre- Funded Warrants In Public Offering | 0000950170-25-069833 | 1 | 0 | monetary | D | C | Issuance Costs Related To Common Stock And Accompanying Pre-funded Warrants In Public Offering | Issuance costs related to common stock and accompanying pre-funded warrants in public offering. |
| Proceeds From Principal Payments On Term Loan | 0000950170-25-069833 | 1 | 0 | monetary | D | D | Proceeds from Principal payments on term loan | Principal payments on term loan |
| Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 0000950170-25-069833 | 1 | 0 | shares | D | Stock Issued During Period, Shares, Exercise Of Pre Funded Warrants | Stock Issued During Period, Shares, Exercise Of Pre Funded Warrants | |
| Stock Issued During Period Value Restricted Stock Unit Vesting | 0000950170-25-069833 | 1 | 0 | monetary | D | D | Stock Issued During Period Value Restricted Stock Unit Vesting | Stock issued during period value restricted stock unit vesting. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Warrant Liability Current | 0000950170-25-069833 | 1 | 0 | monetary | I | C | Warrant Liability Current | Warrant liability current. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Interest And Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Long-Term Debt, Noncurrent | Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Non Cash Interest Expense | 0000950170-25-069833 | 1 | 0 | monetary | D | D | Non Cash Interest Expense | Non-cash interest expense. |
| Stock Issued During Period Shares Restricted Stock Unit Vesting | 0000950170-25-069833 | 1 | 0 | shares | D | Stock Issued During Period Shares Restricted Stock Unit Vesting | Stock issued during period shares restricted stock unit vesting. | |
| Stock Issued During Period Value Exercise Of Pre Funded Warrants | 0000950170-25-069833 | 1 | 0 | monetary | D | C | Stock Issued During Period, Value, Exercise Of Pre Funded Warrants | Equity impact of shares issued on exercise of pre-funded warrants. |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Fair Value Adjustment Of Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Accretion Of Debt Discount | 0000950170-25-069833 | 1 | 0 | monetary | D | D | Accretion of debt discount | Accretion of debt discount. |
| Adjustments To Additional Paid In Capital Mark To Market | us-gaap/2024 | 0 | 0 | monetary | D | C | Adjustments to Additional Paid in Capital, Fair Value | Amount of increase (decrease) to additional paid in capital (APIC) resulting from changes in fair value of common and preferred stock issued to employee benefit trust but unearned. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Long Term Debt Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Other Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets | Amount of assets classified as other. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Treasury Stock Common Shares | us-gaap/2024 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Issuance Costs In Accounts Payable And Accrued Expenses | 0000950170-25-069833 | 1 | 0 | monetary | D | C | Issuance Costs In Accounts Payable And Accrued Expenses | Issuance costs in accounts payable and accrued expenses |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-069833 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-069833 | 2 | 11 | BS | 0 | H | Other Assets | us-gaap/2024 | Other assets | 0 |
| 0000950170-25-069833 | 2 | 5 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-069833 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-069833 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-069833 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Fixed assets, net | 0 |
| 0000950170-25-069833 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Lease right of use assets | 0 |
| 0000950170-25-069833 | 2 | 10 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-069833 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-069833 | 2 | 16 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0000950170-25-069833 | 2 | 17 | BS | 0 | H | Long Term Debt Current | us-gaap/2024 | Current portion of term loan payable to a bank | 0 |
| 0000950170-25-069833 | 2 | 18 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of lease liability | 0 |
| 0000950170-25-069833 | 2 | 19 | BS | 0 | H | Warrant Liability Current | 0000950170-25-069833 | Warrant liability | 0 |
| 0000950170-25-069833 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-069833 | 2 | 21 | BS | 0 | H | Long Term Loans From Bank | us-gaap/2024 | Term loan payable to a bank | 0 |
| 0000950170-25-069833 | 2 | 22 | BS | 0 | H | Other Long Term Debt Noncurrent | us-gaap/2024 | Other long-term debt | 0 |
| 0000950170-25-069833 | 2 | 23 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Lease liability, net of current portion | 0 |
| 0000950170-25-069833 | 2 | 24 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-069833 | 2 | 25 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 14) | 0 |
| 0000950170-25-069833 | 2 | 27 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.01 par value; 10,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued or outstanding at March 31, 2025 and December 31, 2024, respectively; | 0 |
| 0000950170-25-069833 | 2 | 28 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.01 par value; 150,000,000 shares authorized at March 31, 2025 and December 31, 2024; 49,369,749 and 46,933,088 shares issued at March 31, 2025 and December 31, 2024, respectively; 49,247,141 and 46,810,480 shares outstanding at March 31, 2025 and December 31, 2024, respectively. | 0 |
| 0000950170-25-069833 | 2 | 29 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury stock (at cost) | 1 |
| 0000950170-25-069833 | 2 | 30 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-069833 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-069833 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-069833 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-069833 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock par value | 0 |
| 0000950170-25-069833 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0000950170-25-069833 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0000950170-25-069833 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0000950170-25-069833 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-069833 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-069833 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares, issued | 0 |
| 0000950170-25-069833 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares, outstanding | 0 |
| 0000950170-25-069833 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-069833 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-069833 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-069833 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0000950170-25-069833 | 4 | 7 | IS | 0 | H | Interest And Other Income | us-gaap/2024 | Interest income | 0 |
| 0000950170-25-069833 | 4 | 8 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0000950170-25-069833 | 4 | 9 | IS | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2024 | Change in fair value of warrant liability | 1 |
| 0000950170-25-069833 | 4 | 10 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income (expense), net | 0 |
| 0000950170-25-069833 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income (loss) and comprehensive income (loss) | 0 |
| 0000950170-25-069833 | 4 | 12 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net income (loss) per share, basic | 0 |
| 0000950170-25-069833 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average common shares outstanding, basic | 0 |
| 0000950170-25-069833 | 4 | 14 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net income (loss) per share, diluted | 0 |
| 0000950170-25-069833 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average common shares outstanding, diluted | 0 |
| 0000950170-25-069833 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0000950170-25-069833 | 5 | 13 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Beginning Balance, Shares | 0 |
| 0000950170-25-069833 | 5 | 14 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2024 | Beginning Balance, Treasury Stock, Shares | 0 |
| 0000950170-25-069833 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Options exercised | 0 |
| 0000950170-25-069833 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Options exercised, Shares | 0 |
| 0000950170-25-069833 | 5 | 17 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-069833 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Unit Vesting | 0000950170-25-069833 | Restricted stock unit vesting | 0 |
| 0000950170-25-069833 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Unit Vesting | 0000950170-25-069833 | Restricted stock unit vesting, Shares | 0 |
| 0000950170-25-069833 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Exercise Of Pre Funded Warrants | 0000950170-25-069833 | Exercise of pre-funded warrants | 0 |
| 0000950170-25-069833 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 0000950170-25-069833 | Exercise of pre-funded warrants, Shares | 0 |
| 0000950170-25-069833 | 5 | 22 | EQ | 0 | H | Issuance Costs Related To Common Stock And Accompanying Pre- Funded Warrants In Public Offering | 0000950170-25-069833 | Issuance costs related to common stock and accompanying pre-funded warrants in public offering | 0 |
| 0000950170-25-069833 | 5 | 23 | EQ | 0 | H | Adjustments To Additional Paid In Capital Mark To Market | us-gaap/2024 | Change in fair value of NC Ohio Trust Warrants | 0 |
| 0000950170-25-069833 | 5 | 24 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Sale of common stock through at-the-market offerings, net of issuance costs | 0 |
| 0000950170-25-069833 | 5 | 25 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Sale of common stock through at-the-market offerings, net of issuance costs, Shares | 0 |
| 0000950170-25-069833 | 5 | 26 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0000950170-25-069833 | 5 | 27 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0000950170-25-069833 | 5 | 28 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ending Balance, Shares | 0 |
| 0000950170-25-069833 | 5 | 29 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2024 | Ending Balance, Treasury Stock, Shares | 0 |
| 0000950170-25-069833 | 6 | 7 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net income (loss) | 0 |
| 0000950170-25-069833 | 6 | 9 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation expense | 0 |
| 0000950170-25-069833 | 6 | 10 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Non-cash stock compensation expense | 0 |
| 0000950170-25-069833 | 6 | 11 | CF | 0 | H | Non Cash Lease Expense | 0000950170-25-069833 | Non-cash lease expense | 0 |
| 0000950170-25-069833 | 6 | 12 | CF | 0 | H | Non Cash Interest Expense | 0000950170-25-069833 | Non-cash interest expense | 0 |
| 0000950170-25-069833 | 6 | 13 | CF | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2024 | Change in fair value of warrant liability | 0 |
| 0000950170-25-069833 | 6 | 14 | CF | 0 | H | Accretion Of Debt Discount | 0000950170-25-069833 | Accretion of debt discount | 0 |
| 0000950170-25-069833 | 6 | 16 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0000950170-25-069833 | 6 | 17 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Other assets | 1 |
| 0000950170-25-069833 | 6 | 18 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-069833 | 6 | 19 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
| 0000950170-25-069833 | 6 | 20 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Lease liability | 0 |
| 0000950170-25-069833 | 6 | 21 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-069833 | 6 | 23 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of fixed assets | 1 |
| 0000950170-25-069833 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0000950170-25-069833 | 6 | 26 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from option exercises | 0 |
| 0000950170-25-069833 | 6 | 27 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from sale of common stock, net of issuance costs | 0 |
| 0000950170-25-069833 | 6 | 28 | CF | 0 | H | Proceeds From Principal Payments On Term Loan | 0000950170-25-069833 | Principal payments on term loan | 0 |
| 0000950170-25-069833 | 6 | 29 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash used in financing activities | 0 |
| 0000950170-25-069833 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net decrease in cash, cash equivalents and restricted cash | 0 |
| 0000950170-25-069833 | 6 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at beginning of period | 0 |
| 0000950170-25-069833 | 6 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of period | 0 |
| 0000950170-25-069833 | 6 | 34 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0000950170-25-069833 | 6 | 36 | CF | 0 | H | Issuance Costs In Accounts Payable And Accrued Expenses | 0000950170-25-069833 | Issuance costs in accounts payable and accrued expenses | 0 |
| 0000950170-25-069833 | 6 | 37 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | Capital expenditures in accounts payable and accrued expenses | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |